Skip to Content

4214 2.5 (Onglyza saxagliptin 2.5 mg)

Generic Name: saxagliptin

Pill with imprint 4214 2.5 is Yellow, Round and has been identified as Onglyza saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.

Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4214 2.5

Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5 Front
Onglyza saxagliptin 2.5 mg 4214 2.5 Back
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5

Onglyza

Generic Name:
saxagliptin
Imprint:
4214 2.5
Strength:
saxagliptin 2.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00310-6100 AstraZeneca

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide